NovoCure Competitors and Similar CompaniesClear all

NovoCure's competitors and similar companies include Silverback Therapeutics.

	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.	Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
Founding Date	Founding Date 2000	Founding Date 2016
Type	Type Public	Type Public
Tags	Tags Healthcare biotech medical devices oncology platform therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more	Locations Seattle, US HQ
Employees	Employees 1,488	Employees 9067% increase
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 550.4 m
Financial
Revenue (est.)	Revenue (est.) $655.4m (FY, 2025)	Revenue (est.) $1.3m (FY, 2022)
Net income	Net income ($136.2m) (FY, 2025)	Net income ($34.7m) (FY, 2022)

For sources of this data, please see the company profile

Seattle, US

Employees

Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.

Financial